MedImmune Forms Research Partnership
612692
MedImmune Inc. will pay a New Jersey biotech company $15 million to collaborate with it on potential new treatments for autoimmune diseases, starting with lupus. - The Washington Post
681771
Scientists have taken a step closer to  creating a vaccine against a virus that causes the most common  form of diarrhea and vomiting in children.
639682
MedImmune said last week that it has resolved problems with the manufacturing of its nasal flu vaccine FluMist, clearing the way for the Food and Drug Administration to allow the company to ship the product in time for flu season.
64992
Medarex Inc., a Princeton, NJ, biotechnology company, could receive up to $510 million under a global collaboration deal it signed with New York-based Pfizer Inc.
755950
The drugmakers' alliance will benefit both the companies and HIV patients.
232912
It would seem a drug executive&#39;s dream come true. A week ago Thursday, the secretary of health and human services summoned the top officials of MedImmune to his office in Washington to ask
537991
Two University of Oklahoma scientists are starting research that they hope will someday lead to the development of a vaccine to combat the HIV virus, which causes AIDS.
612885
NEW YORK  - The Global HIV/AIDS Vaccine  Enterprise, an international alliance of independent  organizations supporting HIV vaccine research, has issued a  roadmap to speed the development of a vaccine by promoting new  collaboration, resources, and strategic focus.
92270
The Food and Drug Administration yesterday unveiled a proposal designed to give thousands of seriously ill patients easier access to experimental treatments.
42328
A leukemia vaccine has been successful enough in its first trials to warrant larger studies that will include hundreds of patients, researchers report.
410644
University and the Institute for Genomic Research agree to jointly pursue experiments and federal funding in genomics, human health, agriculture, veterinary medicine and biodefense. -The Washington Post
374108
Drug giant Novartis AG says it will give its Cambridge neighbor, MIT, $65 million over 10 years to create a research program, likely to be the biggest in the world aimed at revolutionizing the way drugs are made.
456954
ImmunoGen Inc. of Cambridge is expected to disclose today that it is licensing its cancer-fighting technology to Centocor Inc. , a biotech subsidiary of healthcare giant Johnson &amp; Johnson Inc.
681845
The pharmaceutical giant signs another collaborative research agreement with the small-cap company.
770040
An experimental antibody drug being developed by Danish biotech company Genmab and Britain's GlaxoSmithKline Plc confirmed its promise as a rheumatoid arthritis treatment on Friday.
395582
J&J and Schering revise their agreement over anti-TNF compounds.
86545
For the first time in medical history, scientists have developed a malaria vaccine that has shown promise in a large scale trial conducted in Mozambique.